B1962 injection for advanced colorectal cancer
Part of Cancer clinical trials.
This study tests an investigational drug called B1962 for people with advanced colorectal cancer that has spread or cannot be removed by surgery and has progressed after standard treatments. The goal is to see if B1962 can help control the cancer and be safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have colorectal cancer (including appendix cancer) that has spread or cannot be removed by surgery, and it has worsened or you couldn't tolerate standard treatments that included oxaliplatin, irinotecan, and fluorouracil-based drugs.
- You are able to perform daily activities (ECOG score 0-1) and expected to live more than 3 months.
- You have at least one tumor that can be measured on a CT or MRI scan.
- Your organ and bone marrow function are adequate, with specific blood test requirements.
- If you can become pregnant, you agree to use highly effective contraception and avoid pregnancy during the study and for 3 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called RBS2418 for people with advanced colorectal cancer that has spread and is getting worse, even after other treatments have stopped working. The goal is to see if RBS2418 can help control the cancer.
This study tests an experimental drug called B1962 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective for these cancers.
This study tests a new combination of three drugs for advanced colorectal cancer that has not responded to standard treatments. The goal is to see if this combination can shrink tumors or slow down the cancer's growth.
This trial tests a combination of two oral medications for people with advanced colorectal cancer who cannot tolerate stronger chemotherapy. The goal is to see if this gentler approach slows tumor growth and improves quality of life.
This trial tests a new drug called AT-1965 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and if it can shrink tumors.
This study tests an experimental drug called SHR-A1904 in people with advanced colorectal cancer that has not responded to previous treatments. The goal is to see if the drug can help shrink or control the cancer.
Hear when a new Advanced Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.